$213 | SAVE $37 | Single User
$425 | SAVE $75 | Site License
$638 | SAVE $112 | Global License

Heat Biologics Inc (HTBX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
[Report Updated: 09-11-2018]

Published by Global Data: 09 Nov 2018 | 226879 | In Stock
Related Topics: Healthcare

Introduction

Summary

Heat Biologics Inc (Heat Biologics) is a biopharmaceutical company which develops novel immuno therapeutics for the treatment of cancer. Its pipeline encompasses viagenpumatucel-L based investigational candidate targeted at the treatment of non-small cell lung cancer, and co-stimulatory antibodies targeted at hematologic malignancies, and other tumors. The co-stimulatory antibodies harness human body's natural antigen specific immune response to reprogram the immune system to offer durable clinical outcomes. Heat Biologics’ off-the-shelf therapies are based on its proprietary T-cell activating platform (TCAP), which turns immunologically cold tumors hot. It has subsidiaries in the US, Germany, and Australia. Heat Biologics is headquartered in Durham, North Carolina, the US.

Heat Biologics Inc (HTBX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Heat Biologics Inc (HTBX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 09-11-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 5

    List of Figures 5

    Heat Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

    Heat Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

    Heat Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

    Heat Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

    Heat Biologics Inc, Medical Devices Deals, 2012 to YTD 2018 10

    Heat Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

    Heat Biologics Inc, Pharmaceuticals & Healthcare, Deal Details 12

    Venture Financing 12

    Heat Biologics Raises USD0.5 Million in Venture Funding 12

    Heat Biologics Raises US Million In Venture Financing 13

    Partnerships 14

    Selexis and Pelican Therapeutics Enter into Agreement 14

    Heat Biologics Enters into Agreement with Adaptive Biotechnologies 15

    Licensing Agreements 16

    University of Miami Enters into Licensing Agreement with Heat Biologics 16

    Shattuck Labs Enters into Licensing Agreement with Heat Biologics 18

    Heat Biologics Enters into Licensing Agreement with Columbia University 19

    Heat Biologics Enters into Licensing Agreement for Multiple Myeloma Cell Line 20

    Heat Biologics Enters into Licensing Agreement with University of Miami 21

    Equity Offering 22

    Heat Biologics Files Registration Statement for Public Offering of Shares 22

    Heat Biologics to Raise up to USD15 Million in Public Offering of Shares and Warrants 23

    Heat Biologics Plans to Raise up to USD1.3 Million in Public Offering of Shares 24

    Heat Biologics to Raise up to USD3.7 Million in Public Offering of Shares 25

    Heat Biologics Prices USD2.5 Million of Public Offering of Shares 26

    Heat Biologics Raises USD4 Million in Public Offering of Common Stock 27

    Heat Biologics Raises USD7 Million in Public Offering of Shares 28

    Heat Biologics Raises USD12.3 Million in Public Offering of Shares 30

    Heat Biologics Completes Underwriters’ Partial Exercise Of Over-Allotment Option For IPO Of Shares For US Million 32

    Acquisition 34

    Heat Biologics Acquires 80% Stake in Pelican Therapeutics 34

    Heat Biologics Inc - Key Competitors 35

    Heat Biologics Inc - Key Employees 36

    Heat Biologics Inc - Locations And Subsidiaries 37

    Head Office 37

    Other Locations & Subsidiaries 37

    Recent Developments 38

    Financial Announcements 38

    Aug 14, 2018: Heat Biologics reports second quarter 2018 results and provides corporate update 38

    May 15, 2018: Heat Biologics Reports First Quarter 2018 Results and Provides Corporate Update 39

    Feb 28, 2018: Heat Biologics Reports Fiscal Year 2017 Financial Results 40

    Nov 13, 2017: Heat Biologics Reports Third-quarter 2017 Results and Corporate Update 41

    May 11, 2017: Heat Biologics Provides Business and Clinical Update for the First Quarter of 2017 42

    Mar 31, 2017: Heat Biologics Reports Fiscal Year 2016 Financial Results 44

    Corporate Communications 46

    Feb 28, 2018: Heat Biologics and Its Pelican Therapeutics Subsidiary Appoint Anthony Tolcher, M.D., FRCPC, FACP to their Scientific Advisory Boards 46

    Oct 23, 2017: Heat Biologics and its Pelican Therapeutics Subsidiary Appoint Two New Members to their Scientific Advisory Boards 47

    Jul 03, 2017: Dr. Jeff Hutchins Appointed Chief Operating Officer for Heat Biologics 48

    Jan 04, 2017: Heat Biologics Appoints Jeff Hutchins, Ph.D., as Chief Scientific Officer 49

    Product News 50

    10/30/2017: Pelican Therapeutics, a Subsidiary of Heat Biologics, Receives Second Tranche of its .2 Million CPRIT Grant Award 50

    06/28/2017: Pelican Therapeutics, a Subsidiary of Heat Biologics, Receives First Tranche of .2 Million CPRIT Grant Award 51

    03/16/2017: Florida Department of Health Awards Three-Year Grant to Develop gp96-based Zika Vaccine 52

    Clinical Trials 53

    Nov 11, 2017: Heat Biologics Presents Follow-up Data on its ComPACT(TM) T-cell Stimulating Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 53

    Appendix 54

    Methodology 54

    About GlobalData 54

    Contact Us 54

    Disclaimer 54

List Of Tables
in Heat Biologics Inc (HTBX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 09-11-2018]

List of Tables

Heat Biologics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Heat Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Heat Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Heat Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Heat Biologics Inc, Deals By Therapy Area, 2012 to YTD 2018 9

Heat Biologics Inc, Medical Devices Deals, 2012 to YTD 2018 10

Heat Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Heat Biologics Raises USD0.5 Million in Venture Funding 12

Heat Biologics Raises US Million In Venture Financing 13

Selexis and Pelican Therapeutics Enter into Agreement 14

Heat Biologics Enters into Agreement with Adaptive Biotechnologies 15

University of Miami Enters into Licensing Agreement with Heat Biologics 16

Shattuck Labs Enters into Licensing Agreement with Heat Biologics 18

Heat Biologics Enters into Licensing Agreement with Columbia University 19

Heat Biologics Enters into Licensing Agreement for Multiple Myeloma Cell Line 20

Heat Biologics Enters into Licensing Agreement with University of Miami 21

Heat Biologics Files Registration Statement for Public Offering of Shares 22

Heat Biologics to Raise up to USD15 Million in Public Offering of Shares and Warrants 23

Heat Biologics Plans to Raise up to USD1.3 Million in Public Offering of Shares 24

Heat Biologics to Raise up to USD3.7 Million in Public Offering of Shares 25

Heat Biologics Prices USD2.5 Million of Public Offering of Shares 26

Heat Biologics Raises USD4 Million in Public Offering of Common Stock 27

Heat Biologics Raises USD7 Million in Public Offering of Shares 28

Heat Biologics Raises USD12.3 Million in Public Offering of Shares 30

Heat Biologics Completes Underwriters’ Partial Exercise Of Over-Allotment Option For IPO Of Shares For US Million 32

Heat Biologics Acquires 80% Stake in Pelican Therapeutics 34

Heat Biologics Inc, Key Competitors 35

Heat Biologics Inc, Key Employees 36

Heat Biologics Inc, Subsidiaries 37

List Of Figures, Charts and Diagrams
in Heat Biologics Inc (HTBX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 09-11-2018]

List of Figures

Heat Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Heat Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Heat Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Heat Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Heat Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Heat Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Heat Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Heat Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Heat Biologics Inc, Medical Devices Deals, 2012 to YTD 2018 10

Additional Details

Publisher

Global Data

Publisher Information

Reference

226879 | GDPH135574D

Number of Pages

54

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Sterilization Equipment Market by Product (Moist Heat, Dry Heat, Ethylene Oxide, Filtration, E-beam, Gamma), Services (Onsite & Offsite), Consumables (Indicators, Detergents, Pouches) & End User (Hospitals, Pharmaceuticals) - Global Forecast to 2021
The global sterilization equipment market is poised to reach USD 6.93 billion by 2021 from USD 4.69 ...
14 Dec 2016 by MarketsandMarkets USD $4,803 (normally
USD $5,651)
More Info
SAVE 15% today! Heat Biologics Inc (HTBX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryHeat Biologics Inc (Heat Biologics) is a clinical stage biopharmaceutical company that develo...
28 Nov 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Heat Biologics, Inc. (HTBX) - Financial and Strategic SWOT Analysis Review
SummaryHeat Biologics, Inc. (Heat Biologics) is a clinical-stage biopharmaceutical company that deve...
11 Jul 2016 by Global Data USD $255 (normally
USD $300)
More Info
SAVE 15% today! Aluminum Heat Shield Market- BY END-USE INDUSTRY (AUTOMOTIVE & DEFENSE) AND BY APPLICATION (PASSENGER CARS, LIGHT COMMERCIAL VEHICLES, HEAVY TRUCKS, BUSES & COACHES, AND FIREARMS) GLOBAL FORECAST TO 2021
Aluminum heat shield market projected to reach USD 1.02 billion by 2021The global aluminum heat shie...
01 Jun 2016 by MicroMarketMonitor USD $3,613 (normally
USD $4,251)
More Info
SAVE 15% today! Heat Biologics, Inc. (HTBX) - Financial and Strategic SWOT Analysis Review
SummaryHeat Biologics, Inc. (Heat Biologics) is a clinical-stage biopharmaceutical company that deve...
15 Apr 2016 by Global Data USD $255 (normally
USD $300)
More Info
SAVE 15% today! Heat Biologics, Inc. (HTBX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryHeat Biologics, Inc. (Heat Biologics) is a clinical-stage biopharmaceutical company that deve...
10 Mar 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Heat Biologics, Inc. (HTBX) - Financial and Strategic SWOT Analysis Review
SummaryHeat Biologics, Inc. (Heat Biologics) is a clinical-stage biopharmaceutical company that deve...
09 Jan 2016 by Global Data USD $255 (normally
USD $300)
More Info
SAVE 15% today! North America Seamless Heat Exchanger Tubing Market By Type (Copper Alloy Tubes, Austenitic Steel Tubes, Duplex Steel Tubes, Ni-Alloy Tubes), By End User (Chemicals, Petrochemicals, HVAC & Refrigeration, Food & Beverages, Oil & Gas, Power Generation, Others), By Geography (U.S., Canada, Mexico) – Analysis & Forecast to 2020
The North American seamless heat exchanger tubing market is expected to witness growth during the fo...
01 Jan 2016 by MicroMarketMonitor USD $2,253 (normally
USD $2,651)
More Info
SAVE 15% today! Heat Biologics, Inc. (HTBX) - Financial and Strategic SWOT Analysis Review
SummaryHeat Biologics, Inc. (Heat Biologics) is a clinical-stage biopharmaceutical company that deve...
08 Nov 2015 by Global Data USD $255 (normally
USD $300)
More Info
SAVE 15% today! North America Fire Sensors and Detectors by Component (Smoke Detector, Flame Detector, Heat Detector), By Service (Service & Maintenance, Managed Services, Engineering Services, Installation & Design), by Vertical, by Geography - Analysis & Forecast To 2019
Fire sensor and detection technologies are designed for detecting the presence of smoke, heat, or an...
01 Apr 2015 by MarketsandMarkets USD $2,253 (normally
USD $2,651)
More Info

This report is published by Global Data

Download Free Report Summary PDF

Heat Biologics Inc (HTBX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 09-11-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...